Ankehugen was invited to participate in the Wuxi Biomedical New Track Immersive Experience Exhibition

Date:2024-10-12;

Jiangsu Ankehugen Biotechnology Co., Ltd. was invited to participate in the "Wuxi Biomedical New Track Immersive Experience Exhibition" held by the Wuxi Science and Technology Bureau and the Wuxi Biomedical Industry Development Promotion Center at the Citizen Center.


图片28.png


The exhibition areas mainly include synthetic biology, specialty food, high-end medical aesthetics, and AI pharmaceuticals, with over 50 exhibiting units. The focus is on showcasing new projects and innovative achievements of leading enterprises in the biopharmaceutical industry.


图片29.png


Since its establishment, Ankehugen has been committed to serving the forensic DNA testing industry while focusing on the field of big health. Based on its characteristic testing business, combined with drug therapy and non drug intervention, it creates a healthy and harmonious ecosystem. Synthetic biotechnology is the core of our technological breakthroughs.


图片30.png


At this conference, Ankehugen showcased its latest series of host cell residue test kits, gut microbiota gene sequencing health detection kits, and other products, attracting many synthetic biology friends, technology research institutions, leaders, and others to stop and visit and learn.


图片31.png


Ankehugen always adheres to the development philosophy of quality as the core and user centered. In the future development, Ankehugen will continue to uphold the persistent pursuit of quality and a high sense of responsibility to users, constantly innovate and develop, and provide consumers with better quality products. At the same time, Ankehugen will actively embrace the emerging field of synthetic biology and promote its widespread application and development in the health industry.